儿童手部外骨骼的临床实用性:使用者识别、可行性与接受度及设计改进建议
该横断面评估研究纳入6-18岁因神经系统原因导致至少一只手功能受限的儿童和青少年,使用全可穿戴儿童手部外骨骼(PEXO)进行训练或补偿。结果显示使用PEXO时Assisting Hand Assessment(AHA)缩放分数中位数高于不使用(68 vs 55,p=0.035),接受度普遍较高,但穿戴均需协助且存在传输系统、电子和附件系统等技术问题。
要点
- PEXO可改善手功能极小的年轻患者双手手部表现,且未发生不良事件。
- AHA缩放分数提高≥7分的参与者可通过Box and Block test、选择性上肢控制量表和指伸肌力区分。
- 穿戴背部模块、手套和手部模块的中位时间分别为62、150和160秒,但所有参与者均需协助。
核心结论
- PEXO是一种安全的 exoskeleton,可改善手功能极小的年轻患者的双手手部表现,且接受度较高。
研究设计与样本
- 横断面评估研究,纳入6-18岁因神经系统原因导致至少一只手功能受限的儿童和青少年,共11名同意参与,9名有可用数据。
主要发现
- 使用PEXO时AHA缩放分数中位数为68(IQR 59.5-83),不使用为55(IQR 37.5-80.5),p=0.035。
- Box and Block test、选择性上肢控制量表和指伸肌力可较好区分AHA缩放分数提高≥7分与未提高的参与者,敏感度和特异度在0.75至1.00之间。
- 穿戴背部模块、手套和手部模块的中位时间分别为62秒、150秒和160秒,但所有参与者均需协助。
- 最关键的故障为传输系统、电子设备和附件系统的稳健性,五名参与者出现一些压力点,无不良事件发生。
关键数值与推荐
- AHA缩放分数提高≥7分被用于识别使用手部外骨骼后双手表现改善的儿童。
- Box and Block test、选择性上肢控制量表和指伸肌力被确定为 appropriateness 的临床预测因子,敏感度和特异度在0.75至1.00之间。
临床怎么用
- PEXO可用于改善手功能极小的年轻患者的双手手部表现,但穿戴需协助,且需关注传输系统、电子设备和附件系统的技术问题。
- 在日常生活条件下用于治疗或作为辅助设备前,需根据建议改进技术问题和穿戴流程。
局限性
- 样本量小,仅9名参与者有可用数据。
- 所有参与者穿戴均需协助,技术故障较关键。
- 五名参与者出现压力点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Children and adolescents with upper limb impairments can experience limited bimanual performance reducing daily-life independence. We have developed a fully wearable pediatric hand exoskeleton (PEXO) to train or compensate for impaired hand function. In this study, we investigated its appropriateness, practicability, and acceptability. METHODS: Children and adolescents aged 6-18 years with functional limitations in at least one hand due to a neurological cause were selected for this cross-sectional evaluation. We characterized participants by various clinical tests and quantified bimanual performance with the Assisting Hand Assessment (AHA). We identified children whose AHA scaled score increased by ≥ 7 points when using the hand exoskeleton and determined clinical predictors to investigate appropriateness. The time needed to don each component and the number of technical issues were recorded to evaluate practicability. For acceptability, the experiences of the patients and the therapist with PEXO were evaluated. We further noted any adverse events. RESULTS: Eleven children (median age 11.4 years) agreed to participate, but data was available for nine participants. The median AHA scaled score was higher with PEXO (68; IQR: 59.5-83) than without (55; IQR: 37.5-80.5; p = 0.035). The Box and Block test, the Selective Control of the Upper Extremity Scale, and finger extensor muscle strength could differentiate well between those participants who improved in AHA scaled scores by ≥ 7 points and those who did not (sensitivity and specificity varied between 0.75 and 1.00). The median times needed to don the back module, the glove, and the hand module were 62, 150, and 160 s, respectively, but all participants needed assistance. The most critical failures were the robustness of the transmission system, the electronics, and the attachment system. Acceptance was generally high, particularly in participants who improved bimanual performance with PEXO. Five participants experienced some pressure points. No adverse events occurred. CONCLUSIONS: PEXO is a safe exoskeleton that can improve bimanual hand performance in young patients with minimal hand function. PEXO receives high acceptance. We formulated recommendations to improve technical issues and the donning before such exoskeletons can be used under daily-life conditions for therapy or as an assistive device. Trial registration Not appropriate.
引用
- Lieber J, Dittli J, Lambercy O, et al. Clinical utility of a pediatric hand exoskeleton: identifying users, practicability, and acceptance, and recommendations for design improvement. J Neuroeng Rehabil. 2022. PMID: 35148786. doi:10.1186/s12984-022-00994-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。